Arranz, Alicia <br/><br/>
VIP reverses the expression profiling of TLR4-stimulated signaling pathway in rheumatoid arthritis synovial fibroblasts.  [electronic resource] 

 -  Molecular immunology  Jun 2008 
 - 3065-73 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0161-5890 
<br/><br/><label>Standard No.: </label>10.1016/j.molimm.2008.03.011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Arthritis, Rheumatoid--genetics<br/>Chemokine CCL5--biosynthesis<br/>Down-Regulation--drug effects<br/>Fibroblasts--drug effects<br/>Gene Expression Profiling<br/>Humans<br/>Interleukin-1 Receptor-Associated Kinases--metabolism<br/>Interleukin-6--biosynthesis<br/>Lipopolysaccharides--pharmacology<br/>Models, Immunological<br/>Osteoarthritis--genetics<br/>Protein Serine-Threonine Kinases--metabolism<br/>RNA, Complementary--genetics<br/>RNA, Messenger--genetics<br/>Signal Transduction--drug effects<br/>Synovial Membrane--drug effects<br/>TNF Receptor-Associated Factor 6--immunology<br/>Toll-Like Receptor 4--immunology<br/>Vasoactive Intestinal Peptide--pharmacology